A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer
Clinical trial NCT02296801 · COMPLETED
Trial details
- NCT number
- NCT02296801
- Sponsor
- NSABP Foundation Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2018-07-01
- Enrollment
- 307
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.